|
1
|
Hwang HJ, Park T, Kim M, Shin HS, Hwang W, Min YK, Song SG, Park D, Lee CH. A Novel Therapeutic Reagent, KA-1002 for Alleviating Lysophosphatidic Acid-Mediated Inflammation Related Gene Expression in Swine Macrophages. Animals (Basel) 2020; 10:ani10030534. [PMID: 32210054 PMCID: PMC7142756 DOI: 10.3390/ani10030534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2020] [Revised: 03/16/2020] [Accepted: 03/18/2020] [Indexed: 11/16/2022] Open
Abstract
Simple Summary Inflammatory diseases are a key factor reducing the productivity of animals in a livestock industrial environment. We have identified a novel lysophosphatidic acid signaling antagonist, KA-1002, which alleviates lysophosphatidic acid-mediated a broad range of inflammation related gene expression in swine macrophages. Specifically, we found that KA-1002 significantly alleviated LPA-induced genes related with inflammation such as a role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis and STAT3 signal pathway. Taken together, KA-1002 could be considered a novel therapeutic reagent candidate for swine inflammatory diseases. Abstract Stresses and various infectious reagents caused multiple inflammatory diseases in swine in a livestock industrial environment. Therefore, there is a need for an effective therapeutic or preventive agent that could alleviate chronic and acute inflammation. We found that lysophosphatidic acid (LPA), a stress-induced potent endogenous inflammatory molecule, causes a broad range-regulation of inflammation related genes inflammation in swine macrophages. We further investigated the genome scaled transcriptional regulatory effect of a novel LPA-signaling antagonist, KA-1002 on swine macrophages, inducing the alleviated LPA-mediated inflammation related gene expression. Therefore, KA-1002 could potentially serve as a novel therapeutic or preventive agent to maintain physiologically healthy and balanced conditions of pigs.
Collapse
Affiliation(s)
- Hyeon-Jeong Hwang
- Bio and Drug Discovery Division, Center for Information-Based Drug Research, Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea; (H.-J.H.); (M.K.); (H.-s.S.); (W.H.); (Y.K.M.)
| | - Tamina Park
- Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon 34114, Korea;
- Department of Human and Environmental Toxicology, University of Science and Technology, Daejeon 34113, Korea
| | - Miok Kim
- Bio and Drug Discovery Division, Center for Information-Based Drug Research, Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea; (H.-J.H.); (M.K.); (H.-s.S.); (W.H.); (Y.K.M.)
- Chungnam National University School of Medicine, Daejeon 34137, Korea
| | - Hee-su Shin
- Bio and Drug Discovery Division, Center for Information-Based Drug Research, Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea; (H.-J.H.); (M.K.); (H.-s.S.); (W.H.); (Y.K.M.)
- Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon 34134, Korea
| | - Wooyeon Hwang
- Bio and Drug Discovery Division, Center for Information-Based Drug Research, Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea; (H.-J.H.); (M.K.); (H.-s.S.); (W.H.); (Y.K.M.)
- Department of Pharmaceutical Science, Kyunghee University, Seoul 02447, Korea
| | - Yong Ki Min
- Bio and Drug Discovery Division, Center for Information-Based Drug Research, Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea; (H.-J.H.); (M.K.); (H.-s.S.); (W.H.); (Y.K.M.)
| | - Suk-gil Song
- College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk 28644, Korea;
| | - Daeui Park
- Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon 34114, Korea;
- Department of Human and Environmental Toxicology, University of Science and Technology, Daejeon 34113, Korea
- Correspondence: (D.P.); (C.H.L.); Tel.: +82-42-610-8251 (D.P.); +82-42-860-7414 (C.H.L.)
| | - Chang Hoon Lee
- Bio and Drug Discovery Division, Center for Information-Based Drug Research, Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea; (H.-J.H.); (M.K.); (H.-s.S.); (W.H.); (Y.K.M.)
- Correspondence: (D.P.); (C.H.L.); Tel.: +82-42-610-8251 (D.P.); +82-42-860-7414 (C.H.L.)
| |
Collapse
|